Unihealth Consultancy’s IPO, catering to healthcare services, has commenced its subscription phase, accepting investors’ interests until September 12. While Gray Market Premium (GMP) indicates strong demand with a Rs 30 premium, experts underline fundamental analysis for prudent investments.
Unihealth Consultancy IPO
Unihealth Consultancy’s IPO subscription window, running until September 12, invites investors to participate within the price range of Rs 126-132 per share, available in lots of 1000 shares. Notably, GMP stands at a notable 22.73%, signaling market interest. However, seasoned investors advocate evaluating the company’s financial health before making decisions.
Navigating the Healthcare Landscape
Headquartered in Mumbai, Unihealth Consultancy extends its healthcare services across India and various African nations. The diverse portfolio spans medical centers, hospitals, consultancy services, pharmaceuticals, and medical travel. A significant portion of IPO proceeds will bolster initiatives in Uganda, Nigeria, Tanzania, as well as support subsidiary BioHealth in Tanzania, with additional allocations for corporate needs.
